Standard BioToolsLAB
Market Cap: $720M
About: Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
Employees: 539
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
1,045% more call options, than puts
Call options by funds: $1.26M | Put options by funds: $110K
6% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 36
6% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 36
1% less funds holding
Funds holding: 144 [Q1] → 142 (-2) [Q2]
21.04% less ownership
Funds ownership: 94.08% [Q1] → 73.04% (-21.04%) [Q2]
35% less capital invested
Capital invested by funds: $740M [Q1] → $479M (-$261M) [Q2]
50% less funds holding in top 10
Funds holding in top 10: 4 [Q1] → 2 (-2) [Q2]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
TD Cowen Daniel Brennan 50% 1-year accuracy 2 / 4 met price target | 42%upside $2.75 | Buy Maintained | 1 Aug 2024 |